 |
인쇄하기
취소
|
CrystalGenomics gets U.S. patent on novel cancer candidate
CrystalGenomics, a high-flying Korean biotechnology venture, announced Friday in its regulatory filing that the U.S. Patent and Trademark Office issued the company a patent covering the investigational cancer candidate (code name: CG200745).
The company said it has filed for an international patent in Europe and other countries.
A spokesman for CrystalGenomics said the patent strengthens ...
The company said it has filed for an international patent in Europe and other countries.
A spokesman for CrystalGenomics said the patent strengthens ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.